Closure of a percutaneous tricuspid paravalvular leak with the Amplatzer Muscular VSD device

We present the case of a 16-year-old girl with a prenatal diagnosis of Ebstein's anomaly and an atrial septal defect with severe tricuspid regurgitation. In 2020, the patient was referred due to functional deterioration. Surgical repair included the implantation of a 26-mm Contour 3D tricuspid...

Full description

Saved in:
Bibliographic Details
Published in:REC, Interventional cardiology (Internet. English ed.) Vol. 6; no. 2; pp. 144 - 146
Main Authors: Guillén Mendoza, Noelia B., Abelleira Pardeiro, César, Balbacid Domingo, Enrique J., Galiano, and, Ángela Uceda, Gutiérrez-Larraya Aguado, Federico
Format: Journal Article
Language:English
Published: Permanyer 15-07-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present the case of a 16-year-old girl with a prenatal diagnosis of Ebstein's anomaly and an atrial septal defect with severe tricuspid regurgitation. In 2020, the patient was referred due to functional deterioration. Surgical repair included the implantation of a 26-mm Contour 3D tricuspid annuloplasty ring (Medtronic, United States) with the cone reconstruction technique and closure of the atrial septal defect. During the postoperative follow-up, the patient developed moderate paravalvular leak lateral to the ring that progressed to severe regurgitation with moderate right ventricular dilatation without dysfunction a year and a half later. The patient experienced no episodes of heart failure until 2 years after surgery. Cardiac catheterization was performed via transjugular and right femoral access under general anesthesia and transesophageal echocardiography guidance, revealing the presence of a 13 mm × 10 mm leak posterolateral to the tricuspid annuloplasty ring that appeared as a 15 mm leak on ventriculography (figure 1). The first closure attempt with a 14-mm Konar MF device (Lifetech, China) did not achieve complete closure or attachment at the defect. Therefore, a second attempt was made with an 18-mm Amplatzer Muscular VSD device (Abbott, United States), which achieved proper attachment and almost complete occlusion (figure 2). After release,...
ISSN:2604-7322
2604-7322
DOI:10.24875/RECICE.M23000411